Summit Trail Advisors LLC Has $2.35 Million Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Summit Trail Advisors LLC cut its holdings in The Procter & Gamble Company (NYSE:PG) by 11.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 16,065 shares of the company’s stock after selling 2,077 shares during the quarter. Summit Trail Advisors LLC’s holdings in Procter & Gamble were worth $2,354,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of PG. Dfpg Investments LLC boosted its position in Procter & Gamble by 1.7% during the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock worth $3,680,000 after acquiring an additional 424 shares during the last quarter. Garrett Wealth Advisory Group LLC raised its stake in Procter & Gamble by 6.3% in the 3rd quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock valued at $645,000 after acquiring an additional 260 shares during the period. Herold Advisors Inc. lifted its holdings in Procter & Gamble by 2.2% during the 4th quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock valued at $3,897,000 after purchasing an additional 581 shares during the last quarter. Metis Global Partners LLC boosted its position in Procter & Gamble by 15.7% during the fourth quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock worth $16,858,000 after purchasing an additional 15,599 shares during the period. Finally, N.E.W. Advisory Services LLC lifted its stake in shares of Procter & Gamble by 14.6% during the 3rd quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock worth $13,772,000 after buying an additional 12,016 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

Procter & Gamble stock traded up $0.98 during mid-day trading on Tuesday, reaching $165.42. 1,906,545 shares of the stock traded hands, compared to its average volume of 6,844,294. The business’s 50-day moving average is $160.10 and its 200-day moving average is $154.37. The stock has a market capitalization of $390.41 billion, a PE ratio of 26.87, a price-to-earnings-growth ratio of 3.34 and a beta of 0.43. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $166.04. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. The company’s revenue for the quarter was up .6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.37 EPS. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $1.0065 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.43%. Procter & Gamble’s payout ratio is 65.85%.

Analysts Set New Price Targets

Several research firms have recently commented on PG. Jefferies Financial Group upped their target price on Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a research report on Monday, April 22nd. Barclays upped their price objective on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 23rd. Stifel Nicolaus raised their target price on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a report on Wednesday, January 24th. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Finally, The Goldman Sachs Group began coverage on Procter & Gamble in a research note on Friday, March 1st. They set a “neutral” rating and a $168.00 target price for the company. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $169.76.

Insiders Place Their Bets

In related news, insider Balaji Purushothaman sold 28,369 shares of the stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the completion of the sale, the insider now owns 11,507 shares in the company, valued at $1,858,265.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the sale, the insider now directly owns 11,507 shares in the company, valued at $1,858,265.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Shailesh Jejurikar sold 31,000 shares of the stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $162.90, for a total value of $5,049,900.00. Following the transaction, the chief operating officer now owns 9,739 shares of the company’s stock, valued at $1,586,483.10. The disclosure for this sale can be found here. In the last quarter, insiders sold 86,865 shares of company stock worth $14,059,180. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.